[
  {
    "date": "2023-12-30",
    "symbol": "PHAT",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityinteractivedatacurrent": "Yes",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "currentfiscalyearenddate": "--12-31",
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "PHATHOM PHARMACEUTICALS, INC.",
    "entitycentralindexkey": 1783183,
    "entitytaxidentificationnumber": "82-4151574",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entitywellknownseasonedissuer": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entityfilenumber": "001-39094",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "true",
    "entitysmallbusiness": "true",
    "icfrauditorattestationflag": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "entityincorporationstatecountrycode": "DE",
    "entityaddressaddressline1": "100 Campus Drive",
    "entityaddressaddressline2": "Suite 102",
    "entityaddresscityortown": "Florham Park",
    "entityaddressstateorprovince": "NJ",
    "entityaddresspostalzipcode": 7932,
    "cityareacode": 877,
    "localphonenumber": "742-8466",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "tradingsymbol": "PHAT",
    "securityexchangename": "NASDAQ",
    "auditorname": "Ernst & Young LLP",
    "auditorfirmid": 42,
    "auditorlocation": "Iselin, New Jersey",
    "cashandcashequivalentsatcarryingvalue": 381393000,
    "prepaidexpenseandotherassetscurrent": 13194000,
    "receivablesnetcurrent": 1637000,
    "inventorynet": 1208000,
    "assetscurrent": 397432000,
    "propertyplantandequipmentnet": 2146000,
    "operatingleaserightofuseasset": 1475000,
    "restrictedcash": 2863000,
    "inventorynoncurrent": 8234000,
    "otherassetsnoncurrent": 1692000,
    "assets": 413842000,
    "accountspayablecurrent": 25000,
    "accruedliabilitiescurrent": 17197000,
    "interestpayablecurrent": 1146000,
    "operatingleaseliabilitycurrent": 726000,
    "contractwithcustomerliabilitycurrent": 7111000,
    "liabilitiescurrent": 38781000,
    "longtermdebtnoncurrent": 137842000,
    "contractwithcustomerliabilitynoncurrent": 299816000,
    "operatingleaseliabilitynoncurrent": 462000,
    "otherliabilitiesnoncurrent": 9700000,
    "liabilities": 486601000,
    "commonstockvalue": 5000,
    "additionalpaidincapitalcommonstock": 855921000,
    "retainedearningsaccumulateddeficit": -928685000,
    "stockholdersequity": -72759000,
    "liabilitiesandstockholdersequity": 413842000,
    "accruedexpensesrelatedpartiescurrent": 2694000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 40000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 400000000,
    "commonstocksharesissued": 57970044,
    "commonstocksharesoutstanding": 57970044,
    "treasurystockcommonshares": 19,
    "revenues": 682000,
    "costofrevenue": 167000,
    "grossprofit": 515000,
    "researchanddevelopmentexpense": 49899000,
    "sellinggeneralandadministrativeexpense": 117928000,
    "operatingexpenses": 167827000,
    "operatingincomeloss": -167312000,
    "investmentincomeinterest": 7876000,
    "interestexpense": 41968000,
    "othernonoperatingincomeexpense": -188000,
    "nonoperatingincomeexpense": -34280000,
    "netincomeloss": -201592000,
    "earningspersharebasic": -3.93,
    "earningspersharediluted": -3.93,
    "weightedaveragenumberofsharesoutstandingbasic": 51289092,
    "weightedaveragenumberofdilutedsharesoutstanding": 51289092,
    "researchanddevelopmentexpenserelatedparty": 760000,
    "sellinggeneralandadministrativeexpenserelatedparty": 55000,
    "stockissuedduringperiodvaluestockoptionsexercised": 124000,
    "stockissuedduringperiodsharesstockoptionsexercised": 16421,
    "definedcontributionplanemployerdiscretionarycontributionamount": 1612000,
    "definedcontributionplanemployerdiscretionarymatchnumberofsharessettled": 135956,
    "stockissuedduringperiodvaluesrestrictedsharesperformancestockunitsandrestrictedstockunits": 6000,
    "stockissuedduringperiodsharesrestrictedsharesperformancestockunitsandrestrictedstockunits": 1843954,
    "stockissuedduringperiodvaluenewissues": 1000,
    "stockissuedduringperiodsharesnewissues": 1514219,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 45025000,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 1417000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 196873,
    "profitloss": -201592000,
    "depreciationdepletionandamortization": 575000,
    "sharebasedcompensation": 45025000,
    "paidinkindinterest": 3583000,
    "accruedinterestonrevenueinterestfinancingliability": 24727000,
    "amortizationoffinancingcosts": 1877000,
    "othernoncashincomeexpense": -1869000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 8067000,
    "increasedecreaseinaccountsreceivable": 1637000,
    "increasedecreaseinaccountspayableandaccruedliabilities": 6410000,
    "increasedecreaseininterestpayablenet": 292000,
    "increasedecreaseinoperatingrightofuseassetandleaseliabilities": 194000,
    "increasedecreaseininventories": 9442000,
    "increasedecreaseinothernoncurrentassets": 1394000,
    "netcashprovidedbyusedinoperatingactivities": -137580000,
    "paymentstoacquirepropertyplantandequipment": 1634000,
    "netcashprovidedbyusedininvestingactivities": -1634000,
    "proceedsfromstockoptionsexercised": 124000,
    "proceedsfromissuanceoflongtermdebt": 39318000,
    "proceedsfromissuanceunderwrittenpublicoffering": 141390000,
    "netproceedsfromrevenueinterestfinancingtransaction": 172675000,
    "proceedsfromissuanceofcommonstock": 14073000,
    "netcashprovidedbyusedinfinancingactivities": 367580000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 228366000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 384256000,
    "interestpaidnet": 11133000,
    "capitalexpendituresincurredbutnotyetpaid": 18000,
    "noncashfinalinterestpaymentfee": 2200000,
    "noncashsettlementofemployeestockpurchaseplanliabilityincommonstock": 1417000,
    "noncashsettlementofdefinedcontributionplanliabilityincommonstock": 1612000,
    "increasedecreaseinaccountspayableandaccruedexpensesrelatedparties": 184000,
    "otherlongtermassetspolicytextblock": "Other Long-Term AssetsOther long-term assets consist of deposits relating to our copay and patient support programs and security deposits on our leased properties.",
    "aggregateofferingpricethroughequityfinancing": 150000000,
    "propertyplantandequipmentusefullife": "P2Y",
    "numberofoperatingsegments": 1,
    "taxcutsandjobsactresearchanddevelopmentexpendituresamortizationperiod": "P5Y",
    "accountingstandardsupdateextensiblelist": "http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201613Member",
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "true",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "2023-01-01",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "true",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 34503,
    "numberofcustomersaccountedforaccountsreceivable": 3,
    "concentrationriskpercentage1": 0.87,
    "numberofcustomersaccountedforproductsales": 3,
    "propertyplantandequipmentgross": 1477000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 2046000,
    "depreciationandamortization": 600000,
    "accruedresearchanddevelopmentexpenses": 1009000,
    "accruedemployeebenefitscurrent": 13318000,
    "accruedprofessionalfeescurrent": 1771000,
    "accruedsalescommissioncurrent": 982000,
    "otheraccruedliabilitiescurrent": 117000,
    "inventoryfinishedgoodsnetofreserves": 647000,
    "inventoryrawmaterials": 561000,
    "inventoryrawmaterialsnoncurrent": 8234000,
    "inventorycurrentandnoncurrent": 9442000,
    "accountspayableandaccruedexpensesrelatedpartiescurrent": 28000,
    "operatingcostsandexpenses": 55000,
    "royaltyexpense": 100000,
    "purchaseobligationdueinfirsttwentyfourmonths": 2900000,
    "purchasecommitmentexpense": 300000,
    "lesseeoperatingleaseremainingleaseterm": "P0Y3M18D",
    "lesseeoperatingleasenumberofoptiontoextend": 1,
    "lesseeoperatingleaseoptiontoextend": "operating leases contain an option to extend the term for one additional five-year period",
    "lesseeoperatingleaserenewalterm": "P5Y",
    "operatingleaseexpense": 1100000,
    "operatingleasepayments": 1100000,
    "operatingleaseliability": 1188000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 752000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 513000,
    "lesseeoperatingleaseliabilitypaymentsdue": 1265000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 77000,
    "operatingleaseweightedaverageremainingleaseterm1": "P1Y7M6D",
    "operatingleaseweightedaveragediscountratepercent": 0.0821,
    "longtermdebtnoncurrentexcludingunamortizeddebtdiscount": 148057000,
    "debtinstrumentunamortizeddiscount": 10215000,
    "longtermdebt": 137842000,
    "debtinstrumentcarryingamount": 50000000,
    "debtinstrumentbasisspreadonvariablerate1": 0.0225,
    "debtinstrumentinterestratestatedpercentage": 0.1075,
    "debtinstrumentfinalpaymentfee": 7500000,
    "debtinstrumentfinancialconvenantspercentageofprojectedrevenue": 0.3,
    "interestexpensedebt": 17100000,
    "accruedinterest": 1100000,
    "longtermdebtmaturitiesrepaymentsofprincipalandinterestinyearthree": 7500000,
    "longtermdebtmaturitiesrepaymentsofprincipalandinterestinyearfour": 163444000,
    "longtermdebtandinterest": 170944000,
    "debtinstrumentinterestandfinalpaymentfee": 30944000,
    "investorsrighttoreceiveroyaltiesterminationdescription": "The investors’ right to receive royalties on net sales will terminate when the investors have aggregate payments equal to 200% of the Investment Amount. In addition, at any time after the earlier of (i) April 30, 2024 and (ii) the date that the payment for Erosive GERD regulatory approval is made, the Company has the right to make a cap payment equal to 200% of the Investment Amount less any royalties already paid, at which time the agreement will terminate.",
    "investorsreceiptdescription": "If the investors have not received aggregate payments of at least 100% of the Investment Amount by December 31, 2028, and at least 200% of the Investment Amount by December 31, 2037, each a Minimum Amount, then the Company will be obligated to make a cash payment to the investors in an amount sufficient to gross the investors up to the applicable Minimum Amount.",
    "defaultobligationdescription": "Upon the occurrence of an event of default taking place prior to April 1, 2025, between April 1, 2025 and April 1, 2028, and after April 1, 2028, the Company is obligated to pay 1.30 times Investment Amount, 1.65 times Investment Amount, and 2.0 times investment amount, respectively, less any amounts the Company previously paid pursuant to the agreement.",
    "grossproceedsfromrevenueinterestfinancingagreement": 175000000,
    "paymentoftransactioncosts": 2300000,
    "revenueinterestfinancingliability": 306900000,
    "interestexpenserelatedtorevenueinterestfinancingliability": 24727000,
    "revenueinterestliabilitycurrent": 7111000,
    "revenueinterestfinancingliabilitynoncurrent": 299816000,
    "availableaggregateofferingpricethroughequityfinancing": 150000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsandotherthanoptionsgrantsinperiodgross": 4492336,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsandotherthanoptionsforfeituresandexpirationsinperiod": 2558662,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1474910,
    "sharebasedcompensationarrangementbysharebasedpaymentawardplanmodificationincrementalcompensationcost": 2200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 597650,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 26600000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrantannualincrease": 2086165,
    "allocatedsharebasedcompensationexpense": 19300000,
    "commonstockcapitalsharesreservedforfutureissuance": 91228,
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesissuedinperiod": 196873,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 3.64,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 100000,
    "definedcontributionplancostrecognized": 1900000,
    "definedcontributionplanemployermatchingcontributionpercentofmatch": 0.75,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y4M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 5700000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 2653892,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionssharevesting": 254437,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 1009950,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 63784,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 11.91,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 10.89,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 19.09,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 13.07,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P0Y5M26D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.6973,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0503,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 4550081,
    "sharebasedcompensationarrangementbysharebasedpaymentawardstockoptionsexercisedandsharesvested": 16421,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 2494878,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 2272248,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 4550081,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 11.75,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 8.54,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesandsharesvestedinperiodweightedaverageexerciseprice": 7.54,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 35.96,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 12.65,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 11.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y1M20D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P7Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 3379000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 2088000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 3379000,
    "deferredtaxassetsoperatinglosscarryforwardsnotsubjecttoexpiration": 554700000,
    "operatinglosscarryforwards": 62300000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 11815000,
    "researchanddevelopmenttaxcreditcarryforwardexpirationyear": 2038,
    "unrecognizedtaxbenefits": 3010000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -42334000,
    "incometaxreconciliationstateandlocalincometaxes": -4310000,
    "incometaxreconciliationpermanentitems": 1310000,
    "incometaxreconciliationofficerscompensation": 2534000,
    "incometaxreconciliationtaxcreditsresearch": -2971000,
    "incometaxreconciliationchangeinenactedtaxrate": -3762000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 49745000,
    "incometaxreconciliationotheradjustments": 212000,
    "deferredtaxassetsoperatinglosscarryforwards": 120092000,
    "deferredtaxassetsgoodwillandintangibleassets": 33095000,
    "deferredtaxassetsother": 11256000,
    "deferredtaxassetsgross": 176258000,
    "deferredtaxassetsvaluationallowance": 175915000,
    "deferredtaxassetsnet": 343000,
    "deferredtaxliabilitiesother": 343000,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 51000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 632000
  },
  {
    "date": "2022-12-30",
    "symbol": "PHAT",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityinteractivedatacurrent": "Yes",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "currentfiscalyearenddate": "--12-31",
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "PHATHOM PHARMACEUTICALS, INC.",
    "entitycentralindexkey": 1783183,
    "entitytaxidentificationnumber": "82-4151574",
    "entitycurrentreportingstatus": "Yes ",
    "entityvoluntaryfilers": "No",
    "entitywellknownseasonedissuer": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entityfilenumber": "001-39094",
    "entityshellcompany": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "true",
    "entitysmallbusiness": "true",
    "icfrauditorattestationflag": "false",
    "entityincorporationstatecountrycode": "Delaware",
    "entityaddressaddressline1": "100 Campus Drive",
    "entityaddressaddressline2": "Suite 102",
    "entityaddresscityortown": "Florham Park",
    "entityaddressstateorprovince": "New Jersey",
    "entityaddresspostalzipcode": 7932,
    "cityareacode": 877,
    "localphonenumber": "742-8466",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "tradingsymbol": "PHAT",
    "securityexchangename": "The Nasdaq Global Select Market",
    "auditorname": "Ernst & Young LLP",
    "auditorfirmid": 42,
    "auditorlocation": "Iselin, New Jersey",
    "cashandcashequivalentsatcarryingvalue": 155385000,
    "prepaidexpenseandotherassetscurrent": 5127000,
    "assetscurrent": 160512000,
    "propertyplantandequipmentnet": 1207000,
    "operatingleaserightofuseasset": 2287000,
    "restrictedcash": 505000,
    "otherassetsnoncurrent": 299000,
    "assets": 164810000,
    "accountspayablecurrent": 9997000,
    "accruedliabilitiescurrent": 14678000,
    "interestpayablecurrent": 854000,
    "operatingleaseliabilitycurrent": 708000,
    "liabilitiescurrent": 26237000,
    "longtermdebtnoncurrent": 95264000,
    "revenueinterestfinancingliabilitynoncurrent": 109525000,
    "operatingleaseliabilitynoncurrent": 1098000,
    "otherliabilitiesnoncurrent": 7500000,
    "liabilities": 239624000,
    "commonstockvalue": 3000,
    "additionalpaidincapitalcommonstock": 652276000,
    "retainedearningsaccumulateddeficit": -727093000,
    "stockholdersequity": -727093000,
    "liabilitiesandstockholdersequity": 164810000,
    "accountspayablerelatedpartiescurrent": 35000,
    "accruedexpensesrelatedpartiescurrent": 2499000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": 19,
    "treasurystockcommonshares": 19,
    "researchanddevelopmentexpense": 71441000,
    "generalandadministrativeexpense": 100999000,
    "operatingexpenses": 172440000,
    "operatingincomeloss": -172440000,
    "investmentincomeinterest": 2132000,
    "interestexpense": 27305000,
    "othernonoperatingincomeexpense": -110000,
    "nonoperatingincomeexpense": -25283000,
    "netincomeloss": -197723000,
    "earningspersharebasic": -5.05,
    "earningspersharediluted": -5.05,
    "weightedaveragenumberofsharesoutstandingbasic": "null",
    "weightedaveragenumberofdilutedsharesoutstanding": "null",
    "researchanddevelopmentexpenserelatedparty": 2123000,
    "stockissuedduringperiodsharescashlessexerciseofcommonstockwarrants": "null",
    "cashlessexerciseofcommonstockwarrants": 18,
    "definedcontributionplanemployerdiscretionarycontributionamount": 1116000,
    "definedcontributionplanemployerdiscretionarymatchnumberofsharessettled": 101540,
    "stockissuedduringperiodsharesrestrictedstockawardgross": 992825,
    "stockissuedduringperiodvaluenewissues": 24595000,
    "stockissuedduringperiodsharesnewissues": "null",
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 24133000,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 909000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 89098,
    "profitloss": -197723000,
    "depreciationdepletionandamortization": 620000,
    "sharebasedcompensation": 24133000,
    "paidinkindinterest": 3484000,
    "accruedinterestonrevenueinterestfinancingliability": 14079000,
    "amortizationoffinancingcosts": 2110000,
    "othernoncashincomeexpense": -1329000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 1860000,
    "increasedecreaseinaccountspayableandaccruedliabilities": 8679000,
    "increasedecreaseinclinicalaccruedtrialexpenses": -1402000,
    "increasedecreaseininterestpayablenet": 377000,
    "increasedecreaseinoperatingrightofuseassetandleaseliabilities": -238000,
    "increasedecreaseinothernoncurrentassets": 118000,
    "netcashprovidedbyusedinoperatingactivities": -146530000,
    "paymentstoacquirepropertyplantandequipment": 1041000,
    "netcashprovidedbyusedininvestingactivities": -1041000,
    "netproceedsfromrevenueinterestfinancingtransaction": 95446000,
    "proceedsfromissuanceofcommonstock": 24596000,
    "netcashprovidedbyusedinfinancingactivities": 120042000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -27529000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 155890000,
    "interestpaidnet": 7033000,
    "capitalexpendituresincurredbutnotyetpaid": 138000,
    "noncashsettlementofemployeestockpurchaseplanliabilityincommonstock": 909000,
    "noncashsettlementofdefinedcontributionplanliabilityincommonstock": 1116000,
    "operatingleaseliabilitiesarisingfromobtainingrightofuseassets": 554000,
    "increasedecreaseinaccountspayableandaccruedexpensesrelatedparties": 1139000,
    "propertyplantandequipmentusefullife": " three years",
    "numberofoperatingsegments": 1,
    "taxcutsandjobsactresearchanddevelopmentexpendituresamortizationperiod": 15,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 686703,
    "propertyplantandequipmentgross": 2678000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 1471000,
    "depreciation": 600000,
    "accruedresearchanddevelopmentexpenses": 3080000,
    "accruedemployeebenefitscurrent": 8447000,
    "accruedprofessionalfeescurrent": 3000000,
    "otheraccruedliabilitiescurrent": 151000,
    "accountspayableandaccruedexpensesrelatedpartiescurrent": 1400000,
    "relatedpartytransactionexpensesfromtransactionswithrelatedparty": 1400000,
    "purchaseobligationdueinfirsttwentyfourmonths": 3800000,
    "lesseeoperatingleaseremainingleaseterm": 2.7,
    "lesseeoperatingleasenumberofoptiontoextend": 1,
    "lesseeoperatingleaseoptiontoextend": " operating leases contain an option to extend the term for one additional five-year period",
    "lesseeoperatingleaserenewalterm": "five-year",
    "operatingleaseexpense": 1000000,
    "operatingleasepayments": 1100000,
    "operatingleaseliability": 1806000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 734000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 753000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 513000,
    "lesseeoperatingleaseliabilitypaymentsdue": 2000000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 194000,
    "operatingleaseweightedaverageremainingleaseterm1": 2.6,
    "operatingleaseweightedaveragediscountratepercent": 0.08199999999999999,
    "longtermdebtnoncurrentexcludingunamortizeddebtdiscount": 104474000,
    "debtinstrumentunamortizeddiscount": 9210000,
    "longtermdebt": 95264000,
    "debtinstrumentcarryingamount": 104500000,
    "debtinstrumentfinalpaymentfee": 7500000,
    "interestexpensedebt": 13000000,
    "accruedinterest": 900000,
    "longtermdebtmaturitiesrepaymentsofprincipalandinterestinyearthree": 29707000,
    "longtermdebtmaturitiesrepaymentsofprincipalandinterestinyearfour": 94764000,
    "longtermdebtandinterest": 124471000,
    "debtinstrumentinterestandfinalpaymentfee": 24471000,
    "investorsrighttoreceiveroyaltiesterminationdescription": "The investors’ right to receive royalties on net sales will terminate when the investors have aggregate payments equal to 200% of the Investment Amount. In addition, at any time after the earlier of (i) April 30, 2024 and (ii) the date that the payment for erosive GERD regulatory approval is made, the Company has the right to make a cap payment equal to 200% of the Investment Amount less any royalties already paid, at which time the agreement will terminate.",
    "investorsreceiptdescription": "If the investors have not received aggregate payments of at least 100% of the Investment Amount by December 31, 2028, and at least 200% of the Investment Amount by December 31, 2037, each a Minimum Amount, then the Company will be obligated to make a cash payment to the investors in an amount sufficient to gross the investors up to the applicable Minimum Amount.",
    "defaultobligationdescription": "Upon the occurrence of an event of default taking place prior to April 1, 2025, between April 1, 2025, and April 1, 2028, and after April 1, 2028, the Company is obligated to pay 1.30 times Investment Amount, 1.65 times Investment Amount, and 2.0 times investment amount, respectively, less any amounts the Company previously paid pursuant to the agreement. ",
    "changeincontroldescription": "Upon the occurrence of a change in control event taking place prior to the earlier of April 1, 2024, or FDA approval of vonoprazan for erosive GERD, the Company is obligated to pay 200% of the Investment Amount plus either 15% of the Investment Amount if occurrence prior to May 3, 2023, or plus 30% of the Investment Amount if occurrence thereafter.",
    "grossproceedsfromrevenueinterestfinancingagreement": 100000000,
    "paymentoftransactioncosts": 4600000,
    "revenueinterestfinancingliability": 109500000,
    "interestexpenserelatedtorevenueinterestfinancingliability": 14079000,
    "stockrepurchaseprogramremainingnumberofsharesauthorizedtoberepurchased": 175373,
    "amountutilizedofequityfinancing": 25400000,
    "availableaggregateofferingpricethroughequityfinancing": 125000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsandotherthanoptionsgrantsinperiodgross": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsandotherthanoptionsforfeituresandexpirationsinperiod": 392207,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": "null",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 7200000,
    "allocatedsharebasedcompensationexpense": 24133000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 12800000,
    "commonstockcapitalsharesreservedforfutureissuance": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesissuedinperiod": 89098,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 8.4,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 37300000,
    "definedcontributionplancostrecognized": 1300000,
    "definedcontributionplanemployermatchingcontributionpercentofmatch": 0.75,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 877467,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionssharevesting": 890372,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 102453,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 30517,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 11.03,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 10.79,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 8.51,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 12.14,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 5.88,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.66,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0206,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 342190,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 23.4,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 14.62,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 29.32,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 7.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 7.18,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 4476000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 2867000,
    "deferredtaxassetsoperatinglosscarryforwardsnotsubjecttoexpiration": 408700000,
    "operatinglosscarryforwards": 1700000,
    "operatinglosscarryforwardsexpirationyear": 2036,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 900000,
    "researchanddevelopmenttaxcreditcarryforwardexpirationyear": 2025,
    "unrecognizedtaxbenefits": 2327000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -41522000,
    "incometaxreconciliationpermanentitems": 2713000,
    "incometaxreconciliationtaxcreditsresearch": 2453000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 41137000,
    "incometaxreconciliationotheradjustments": 125000,
    "deferredtaxassetsoperatinglosscarryforwards": 85918000,
    "deferredtaxassetsgoodwillandintangibleassets": 25319000,
    "deferredtaxassetsother": 6517000,
    "deferredtaxassetsgross": 126651000,
    "deferredtaxassetsvaluationallowance": 126170000,
    "deferredtaxassetsnet": 481000,
    "deferredtaxliabilitiesother": 481000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 623000
  },
  {
    "date": "2021-12-30",
    "symbol": "PHAT",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityinteractivedatacurrent": "Yes",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "currentfiscalyearenddate": "--12-31",
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "PHATHOM PHARMACEUTICALS, INC.",
    "entitycentralindexkey": 1783183,
    "entitytaxidentificationnumber": "82-4151574",
    "entitycurrentreportingstatus": "Yes ",
    "entityvoluntaryfilers": "No",
    "entitywellknownseasonedissuer": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entityfilenumber": "001-39094",
    "entityshellcompany": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "true",
    "entitysmallbusiness": "true",
    "icfrauditorattestationflag": "false",
    "entityincorporationstatecountrycode": "Delaware",
    "entityaddressaddressline1": "100 Campus Drive",
    "entityaddressaddressline2": "Suite 102",
    "entityaddresscityortown": "Florham Park",
    "entityaddressstateorprovince": "New Jersey",
    "entityaddresspostalzipcode": 7932,
    "cityareacode": 877,
    "localphonenumber": "742-8466",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "tradingsymbol": "PHAT",
    "securityexchangename": "The Nasdaq Global Select Market",
    "auditorname": "Ernst & Young LLP",
    "auditorfirmid": 42,
    "auditorlocation": "Iselin, New Jersey",
    "cashandcashequivalentsatcarryingvalue": 183259000,
    "prepaidexpenseandotherassetscurrent": 3267000,
    "assetscurrent": 186526000,
    "propertyplantandequipmentnet": 650000,
    "operatingleaserightofuseasset": 1914000,
    "otherassetsnoncurrent": 341000,
    "assets": 189431000,
    "accountspayablecurrent": 5150000,
    "accruedclinicaltrialexpensescurrent": 1402000,
    "accruedliabilitiescurrent": 11405000,
    "interestpayablecurrent": 477000,
    "operatingleaseliabilitycurrent": 487000,
    "liabilitiescurrent": 18921000,
    "longtermdebtnoncurrent": 89671000,
    "operatingleaseliabilitynoncurrent": 1183000,
    "otherliabilitiesnoncurrent": 7500000,
    "liabilities": 117275000,
    "commonstockvalue": 3000,
    "additionalpaidincapitalcommonstock": 601523000,
    "retainedearningsaccumulateddeficit": -529370000,
    "stockholdersequity": -529370000,
    "liabilitiesandstockholdersequity": 189431000,
    "accountspayablerelatedpartiescurrent": 1343000,
    "accruedexpensesrelatedpartiescurrent": 2330000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "researchanddevelopmentexpense": 72338000,
    "generalandadministrativeexpense": 62742000,
    "operatingexpenses": 135080000,
    "operatingincomeloss": -135080000,
    "investmentincomeinterest": 41000,
    "interestexpense": 6788000,
    "othernonoperatingincomeexpense": -2056000,
    "nonoperatingincomeexpense": -8803000,
    "netincomeloss": -143883000,
    "earningspersharebasicanddiluted": -3.89,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": "null",
    "researchanddevelopmentexpenserelatedparty": 4933000,
    "generalandadministrativeexpenserelatedparty": 18000,
    "stockissuedduringperiodvaluestockoptionsexercised": 1944000,
    "stockissuedduringperiodsharesstockoptionsexercised": 107583,
    "stockissuedduringperiodsharesexerciseofwarrants": 228696,
    "definedcontributionplanemployerdiscretionarycontributionamount": 903000,
    "definedcontributionplanemployerdiscretionarymatchnumberofsharessettled": 26750,
    "stockissuedduringperiodsharesrestrictedstockawardgross": "null",
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 16812000,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 819000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 30237,
    "adjustmentstoadditionalpaidincapitalwarrantissued": 300000,
    "profitloss": -143883000,
    "depreciationdepletionandamortization": 521000,
    "sharebasedcompensation": 16812000,
    "paidinkindinterest": 990000,
    "amortizationoffinancingcosts": 3595000,
    "othernoncashincomeexpense": -823000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -605000,
    "increasedecreaseinaccountspayableandaccruedliabilities": -9791000,
    "increasedecreaseinclinicalaccruedtrialexpenses": -18595000,
    "increasedecreaseininterestpayablenet": 165000,
    "increasedecreaseinoperatingrightofuseassetandleaseliabilities": 98000,
    "increasedecreaseinothernoncurrentassets": -43000,
    "netcashprovidedbyusedinoperatingactivities": -148617000,
    "paymentstoacquirepropertyplantandequipment": 328000,
    "netcashprovidedbyusedininvestingactivities": -328000,
    "proceedsfromstockoptionsexercised": 1944000,
    "repaymentsoflongtermdebt": 54125000,
    "proceedsfromissuanceoflongtermdebt": 96889000,
    "netcashprovidedbyusedinfinancingactivities": 44708000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -104237000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 183259000,
    "interestpaidnet": 4069000,
    "noncashissuanceofcommonstockwarrantsinconnectionwithlongtermdebt": 1290000,
    "capitalexpendituresincurredbutnotyetpaid": 2000,
    "noncashfinalinterestpaymentfee": 7500000,
    "noncashsettlementofemployeestockpurchaseplanliabilityincommonstock": 819000,
    "noncashsettlementofdefinedcontributionplanliabilityincommonstock": 903000,
    "increasedecreaseinprepaidexpensesandotherassetsrelatedpartiescurrent": 82000,
    "increasedecreaseinaccountspayableandaccruedexpensesrelatedparties": 2766000,
    "propertyplantandequipmentusefullife": " three years",
    "numberofoperatingsegments": 1,
    "incrementalcommonsharesattributabletoexerciseofwarrants": "null",
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrightsremainsexercisable": "null",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "adopted",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "January 1, 2021",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "not",
    "propertyplantandequipmentgross": 1502000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 852000,
    "depreciation": 500000,
    "accruedresearchanddevelopmentexpenses": 3165000,
    "accruedemployeebenefitscurrent": 6344000,
    "accruedprofessionalfeescurrent": 1855000,
    "otheraccruedliabilitiescurrent": 41000,
    "accountspayableandaccruedexpensesrelatedpartiescurrent": 200000,
    "relatedpartytransactionsharedoperatingexpensesduetotransactionswithrelatedparty": 18000,
    "relatedpartytransactionexpensesfromtransactionswithrelatedparty": 1800000,
    "purchaseobligation": 400000,
    "purchaseobligationdueinfirsttwentyfourmonths": 3800000,
    "lesseeoperatingleaseremainingleaseterm": 3.7,
    "lesseeoperatingleasenumberofoptiontoextend": 1,
    "lesseeoperatingleaseoptiontoextend": "Both operating leases contain an option to extend the term for one additional five-year period",
    "lesseeoperatingleaserenewalterm": "five-year",
    "operatingleaseexpense": 700000,
    "operatingleasepayments": 100000,
    "operatingleaseliability": 1670000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 503000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 516000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 529000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 342000,
    "lesseeoperatingleaseliabilitypaymentsdue": 1890000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 220000,
    "operatingleaseweightedaverageremainingleaseterm1": 3.56,
    "operatingleaseweightedaveragediscountratepercent": 0.0725,
    "longtermdebtnoncurrentexcludingunamortizeddebtdiscount": 100990000,
    "debtinstrumentunamortizeddiscount": 11319000,
    "longtermdebt": 89671000,
    "debtinstrumentcarryingamount": 101000000,
    "debtinstrumentfinalpaymentfee": 4099999.9999999995,
    "repaymentsofdebt": 54300000,
    "debtinstrumentinterestrateeffectivepercentage": 0.0725,
    "interestexpensedebt": 6800000,
    "accruedinterest": 500000,
    "longtermdebtmaturitiesrepaymentsofprincipalandinterestduenexttwelvemonths": 5704000,
    "longtermdebtmaturitiesrepaymentsofprincipalandinterestinyeartwo": 5900000,
    "longtermdebtmaturitiesrepaymentsofprincipalandinterestinyearthree": 17308000,
    "longtermdebtmaturitiesrepaymentsofprincipalandinterestinyearfour": 50912000,
    "longtermdebtmaturitiesrepaymentsofprincipalandinterestinyearfive": 66948000,
    "longtermdebtandinterest": 146772000,
    "debtinstrumentinterestandfinalpaymentfee": 46772000,
    "stockrepurchaseprogramremainingnumberofsharesauthorizedtoberepurchased": 749488,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 842036,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsandotherthanoptionsgrantsinperiodgross": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsandotherthanoptionsforfeituresandexpirationsinperiod": 175430,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 190050,
    "allocatedsharebasedcompensationexpense": 16812000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 12700000,
    "commonstockcapitalsharesreservedforfutureissuance": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesissuedinperiod": 30237,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 22.2,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 46600000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.6,
    "closingmarketpriceofcommonstock": 19.67,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 1700000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 394300,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionssharevesting": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 15750,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 32.23,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 31.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 30.63,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 5.93,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.6746,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0068000000000000005,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardstockoptionsexercisedandsharesvested": -107583,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 159680,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 27.53,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 37.14,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesandsharesvestedinperiodweightedaverageexerciseprice": 18.07,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 32.26,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 19.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 27.53,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 8.43,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 7.91,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": 8.43,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 13973000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 6880000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 13973000,
    "deferredtaxassetsoperatinglosscarryforwardsnotsubjecttoexpiration": 290100000,
    "operatinglosscarryforwards": 400000,
    "operatinglosscarryforwardsexpirationyear": 2036,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 700000,
    "researchanddevelopmenttaxcreditcarryforwardexpirationyear": 2025,
    "unrecognizedtaxbenefits": 1704000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -30216000,
    "incometaxreconciliationpermanentitems": 1387000,
    "incometaxreconciliationtaxcreditsresearch": 2950000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 31783000,
    "incometaxreconciliationotheradjustments": -4000,
    "deferredtaxassetsoperatinglosscarryforwards": 60936000,
    "deferredtaxassetsgoodwillandintangibleassets": 13809000,
    "deferredtaxassetsother": 3996000,
    "deferredtaxassetsgross": 85435000,
    "deferredtaxassetsvaluationallowance": 85033000,
    "deferredtaxassetsnet": 402000,
    "deferredtaxliabilitiesother": 402000,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 64000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 702000,
    "definedcontributionplancostrecognized": 800000,
    "definedcontributionplanemployermatchingcontributionpercentofmatch": 0.75
  },
  {
    "date": "2020-12-30",
    "symbol": "PHAT",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityinteractivedatacurrent": "Yes",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalyearfocus": 2020,
    "currentfiscalyearenddate": "--12-31",
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "PHATHOM PHARMACEUTICALS, INC.",
    "entitycentralindexkey": 1783183,
    "entitytaxidentificationnumber": "82-4151574",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entitywellknownseasonedissuer": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entityfilenumber": "001-39094",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "true",
    "entitysmallbusiness": "true",
    "icfrauditorattestationflag": "false",
    "entityincorporationstatecountrycode": "DE",
    "entityaddressaddressline1": "100 Campus Drive",
    "entityaddressaddressline2": "Suite 102",
    "entityaddresscityortown": "Florham Park",
    "entityaddressstateorprovince": "NJ",
    "entityaddresspostalzipcode": 7932,
    "cityareacode": 877,
    "localphonenumber": "742-8466",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "tradingsymbol": "PHAT",
    "securityexchangename": "NASDAQ",
    "cashandcashequivalentsatcarryingvalue": 287496000,
    "prepaidexpenseandotherassetscurrent": 3872000,
    "assetscurrent": 291368000,
    "propertyplantandequipmentnet": 986000,
    "operatingleaserightofuseasset": 2373000,
    "otherassetsnoncurrent": 384000,
    "assets": 295111000,
    "accountspayablecurrent": 16782000,
    "accruedclinicaltrialexpensescurrent": 19997000,
    "accruedliabilitiescurrent": 10606000,
    "interestpayablecurrent": 312000,
    "longtermdebtcurrent": 7353000,
    "operatingleaseliabilitycurrent": 474000,
    "liabilitiescurrent": 55524000,
    "longtermdebtnoncurrent": 39634000,
    "operatingleaseliabilitynoncurrent": 1557000,
    "otherliabilitiesnoncurrent": 4125000,
    "liabilities": 100840000,
    "commonstockvalue": 3000,
    "additionalpaidincapitalcommonstock": 579755000,
    "retainedearningsaccumulateddeficit": -385487000,
    "stockholdersequity": -385487000,
    "liabilitiesandstockholdersequity": 295111000,
    "prepaidexpensesandotherassetsrelatedpartiescurrent": 82000,
    "accountspayablerelatedpartiescurrent": 173000,
    "accruedexpensesrelatedpartiescurrent": 734000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 40000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 400000000,
    "commonstocksharesissued": 31262769,
    "commonstocksharesoutstanding": 28516010,
    "researchanddevelopmentexpense": 98148000,
    "generalandadministrativeexpense": 27517000,
    "operatingexpenses": 125665000,
    "operatingincomeloss": -125665000,
    "investmentincomeinterest": 1091000,
    "interestexpense": 4581000,
    "fairvalueadjustmentofwarrants": -95000,
    "othernonoperatingincomeexpense": -8000,
    "nonoperatingincomeexpense": -3403000,
    "netincomeloss": -129068000,
    "earningspersharebasicanddiluted": -3.88,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 33228158,
    "researchanddevelopmentexpenserelatedparty": 2812000,
    "generalandadministrativeexpenserelatedparty": 157000,
    "stockissuedduringperiodvaluenewissues": 88596000,
    "stockissuedduringperiodsharesnewissues": 2250000,
    "adjustmentstoadditionalpaidincapitalconversionofwarrantliabilityintoequity": 400000,
    "stockissuedduringperiodvaluestockoptionsexercised": 629000,
    "stockissuedduringperiodsharesstockoptionsexercised": 48263,
    "stockissuedduringperiodvaluerestrictedstockawardgross": 1000,
    "stockissuedduringperiodsharesrestrictedstockawardgross": 1489489,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 5840000,
    "profitloss": -129068000,
    "depreciationdepletionandamortization": 323000,
    "sharebasedcompensation": 5840000,
    "amortizationoffinancingcosts": 1273000,
    "otherexpenses": 322000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -7963000,
    "increasedecreaseinaccountspayableandaccruedliabilities": 24009000,
    "increasedecreaseinclinicalaccruedtrialexpenses": 19997000,
    "increasedecreaseininterestpayablenet": 156000,
    "increasedecreaseinoperatingrightofuseassetandleaseliabilities": -205000,
    "increasedecreaseinothernoncurrentassets": 203000,
    "netcashprovidedbyusedinoperatingactivities": -69688000,
    "paymentstoacquirepropertyplantandequipment": 1040000,
    "netcashprovidedbyusedininvestingactivities": -1040000,
    "proceedsfromunderwrittenpublicofferingnet": 88830000,
    "proceedsfromstockoptionsexercised": 629000,
    "proceedsfromissuanceoflongtermdebt": 25000000,
    "netcashprovidedbyusedinfinancingactivities": 114459000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 43731000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 287496000,
    "interestpaidnet": 3464000,
    "capitalexpendituresincurredbutnotyetpaid": 145000,
    "noncashfinalinterestpaymentfee": 2063000,
    "operatingleaseliabilitiesarisingfromobtainingrightofuseassets": 1396000,
    "conversionofwarrantliabilitiesintoequity": 318000,
    "unpaidunderwrittenpublicofferingcosts": 234000,
    "increasedecreaseinprepaidexpensesandotherassetsrelatedpartiescurrent": -82000,
    "increasedecreaseinaccountspayableandaccruedexpensesrelatedparties": 399000,
    "sharesissuedpricepershare": 39.48,
    "deferredofferingcosts": 200000,
    "propertyplantandequipmentusefullife": "P3Y",
    "numberofoperatingsegments": 1,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 3424676,
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "true",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "2020-01-01",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "true",
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilityperiodincreasedecrease": -95000,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisreclassofwarrantsintoequity": 318000,
    "propertyplantandequipmentgross": 1317000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 331000,
    "depreciation": 300000,
    "accruedresearchanddevelopmentexpenses": 4864000,
    "accruedemployeebenefitscurrent": 4587000,
    "accruedprofessionalfeescurrent": 1123000,
    "otheraccruedliabilitiescurrent": 32000,
    "accountspayableandaccruedexpensesrelatedpartiescurrent": 200000,
    "relatedpartytransactionsharedoperatingexpensesduetotransactionswithrelatedparty": 200000,
    "relatedpartytransactionexpensesfromtransactionswithrelatedparty": 200000,
    "purchaseobligation": 2200000,
    "purchaseobligationdueinfirsttwentyfourmonths": 3800000,
    "debtinstrumentinterestrateeffectivepercentage": 0.05,
    "interestexpensedebt": 4600000,
    "lesseeoperatingleaseremainingleaseterm": "P4Y8M12D",
    "lesseeoperatingleasenumberofoptiontoextend": 1,
    "lesseeoperatingleaseoptiontoextend": "Both operating leases contain an option to extend the term for one additional five-year period",
    "lesseeoperatingleaseexistenceofoptiontoterminate": "true",
    "lesseeoperatingleaserenewalterm": "P5Y",
    "operatingleaseexpense": 500000,
    "operatingleasepayments": 600000,
    "operatingleaseliability": 2031000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 490000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 503000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 516000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 529000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 342000,
    "lesseeoperatingleaseliabilitypaymentsdue": 2380000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 349000,
    "operatingleaseweightedaverageremainingleaseterm1": "P4Y6M21D",
    "operatingleaseweightedaveragediscountratepercent": 0.0725,
    "longtermdebtnoncurrentexcludingunamortizeddebtdiscount": 42647000,
    "debtinstrumentunamortizeddiscount": 3013000,
    "longtermdebt": 46987000,
    "debtinstrumentpaymentterms": "Under the original Loan Agreement, the monthly payments consisted of interest-only through May 31, 2021.",
    "adjustmentstoadditionalpaidincapitalwarrantissued": 300000,
    "debtinstrumentcarryingamount": 50000000,
    "accruedinterest": 300000,
    "longtermdebtmaturitiesrepaymentsofprincipalandinterestduenexttwelvemonths": 10938000,
    "longtermdebtmaturitiesrepaymentsofprincipalandinterestinyeartwo": 20187000,
    "longtermdebtmaturitiesrepaymentsofprincipalandinterestinyearthree": 18889000,
    "longtermdebtmaturitiesrepaymentsofprincipalandinterestinyearfour": 11614000,
    "longtermdebtandinterest": 61628000,
    "debtinstrumentinterestandfinalpaymentfee": 11628000,
    "stockrepurchaseprogramremainingnumberofsharesauthorizedtoberepurchased": 1323606,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 559645,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1376477,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 220000,
    "allocatedsharebasedcompensationexpense": 5840000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 7100000,
    "commonstockcapitalsharesreservedforfutureissuance": 13374936,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 19.59,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 28200000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P3Y9M18D",
    "closingmarketpriceofcommonstock": 33.22,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 1500000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 220000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionssharevesting": 1489489,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 32.48,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 32.48,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y21D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.6507,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0051,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 2728742,
    "sharebasedcompensationarrangementbysharebasedpaymentawardstockoptionsexercisedandsharesvested": -48263,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 345043,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 2728742,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 21.36,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 33.55,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesandsharesvestedinperiodweightedaverageexerciseprice": 13.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 8.98,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 21.36,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P9Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P8Y8M4D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P9Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 34432000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 8362000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 34432000,
    "deferredtaxassetsoperatinglosscarryforwardsnotsubjecttoexpiration": 157800000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 4700000,
    "researchanddevelopmenttaxcreditcarryforwardexpirationyear": 2038,
    "unrecognizedtaxbenefits": 938000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -27105000,
    "incometaxreconciliationpermanentitems": 291000,
    "incometaxreconciliationchangeinfairvalueofwarrantsandconvertibledebt": -20000,
    "incometaxreconciliationtaxcreditsresearch": 3047000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 29949000,
    "incometaxreconciliationotheradjustments": -68000,
    "deferredtaxassetsoperatinglosscarryforwards": 33162000,
    "deferredtaxassetsgoodwillandintangibleassets": 14929000,
    "deferredtaxassetsother": 1914000,
    "deferredtaxassetsgross": 53749000,
    "deferredtaxassetsvaluationallowance": 53250000,
    "deferredtaxassetsnet": 499000,
    "deferredtaxliabilitiesother": 499000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 762000,
    "definedcontributionplancostrecognized": 300000,
    "definedcontributionplansliabilities": 300000,
    "definedcontributionplanemployermatchingcontributionpercentofmatch": 0.75
  },
  {
    "date": "2019-12-30",
    "symbol": "PHAT",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityinteractivedatacurrent": "Yes",
    "documentperiodenddate": "2019-12-31",
    "documentfiscalyearfocus": 2019,
    "currentfiscalyearenddate": "--12-31",
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "PHATHOM PHARMACEUTICALS, INC.",
    "entitycentralindexkey": 1783183,
    "entitytaxidentificationnumber": "82-4151574",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entitywellknownseasonedissuer": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entityfilenumber": "001-39094",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "true",
    "entitysmallbusiness": "true",
    "entityincorporationstatecountrycode": "DE",
    "entityaddressaddressline1": "100 Campus Drive",
    "entityaddressaddressline2": "Suite 102",
    "entityaddresscityortown": "Florham Park",
    "entityaddressstateorprovince": "NJ",
    "entityaddresspostalzipcode": 7932,
    "cityareacode": 877,
    "localphonenumber": "742-8466",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "tradingsymbol": "PHAT",
    "securityexchangename": "NASDAQ",
    "cashandcashequivalentsatcarryingvalue": 243765000,
    "prepaidexpenseandotherassetscurrent": 11836000,
    "assetscurrent": 255601000,
    "propertyplantandequipmentnet": 463000,
    "operatingleaserightofuseasset": 933000,
    "otherassetsnoncurrent": 181000,
    "assets": 257178000,
    "accountspayablecurrent": 699000,
    "accruedliabilitiescurrent": 2319000,
    "interestpayablecurrent": 156000,
    "operatingleaseliabilitycurrent": 161000,
    "warrantliabilitycurrent": 413000,
    "liabilitiescurrent": 3748000,
    "longtermdebt": 22777000,
    "operatingleaseliabilitynoncurrent": 635000,
    "otherliabilitiesnoncurrent": 2063000,
    "liabilities": 29223000,
    "commonstockvalue": 2000,
    "additionalpaidincapitalcommonstock": 484372000,
    "retainedearningsaccumulateddeficit": -256419000,
    "stockholdersequity": -256419000,
    "liabilitiesandstockholdersequity": 257178000,
    "accountspayablerelatedpartiescurrent": 200000,
    "accruedexpensesrelatedpartiescurrent": 308000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 400000000,
    "commonstocksharesissued": 28964506,
    "commonstocksharesoutstanding": 24728258,
    "researchanddevelopmentexpense": 20374000,
    "processresearchanddevelopment": 78897000,
    "generalandadministrativeexpense": 6944000,
    "operatingexpenses": 106215000,
    "operatingincomeloss": -106215000,
    "investmentincomeinterest": 1089000,
    "interestexpense": 4177000,
    "fairvalueadjustmentofwarrants": 96272000,
    "changeinfairvalueofconvertiblepromissorynotes": -49546000,
    "othernonoperatingincomeexpense": -10000,
    "nonoperatingincomeexpense": -148916000,
    "netincomeloss": -255131000,
    "earningspersharebasicanddiluted": -22.45,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 11366916,
    "researchanddevelopmentexpenserelatedparty": 1243000,
    "generalandadministrativeexpenserelatedparty": 312000,
    "interestexpenserelatedparty": 590000,
    "changeinfairvalueofwarrantliabilitiesrelatedparty": 96278000,
    "changeinfairvalueofconvertiblepromissorynotesrelatedparty": 10941000,
    "stockissuedduringperiodsharesacquisitions": 6760334,
    "vestingrestrictionsplacedonpreviouslyissuedandoutstandingsharesofcommonstock": 3373408,
    "stockissuedduringperiodvaluenewissues": 191472000,
    "stockissuedduringperiodsharesnewissues": 10997630,
    "adjustmentstoadditionalpaidincapitalconversionofwarrantliabilityintoequity": 144172000,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 142437000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 6107918,
    "stockissuedduringperiodsharesrestrictedstockawardgross": 1660712,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 406000,
    "profitloss": -255131000,
    "depreciationdepletionandamortization": 8000,
    "sharebasedcompensation": 406000,
    "amortizationoffinancingcosts": 409000,
    "researchanddevelopmentinprocess": 78897000,
    "interestexpenseother": 2605000,
    "fairvalueadjustmentofconvertiblepromissorynotes": 49546000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 11813000,
    "increasedecreaseinaccountspayableandaccruedliabilities": 2265000,
    "increasedecreaseininterestpayablenet": 156000,
    "increasedecreaseinoperatingrightofuseassetandleaseliabilities": 51000,
    "increasedecreaseinothernoncurrentassets": 181000,
    "netcashprovidedbyusedinoperatingactivities": -36510000,
    "paymentstoacquireinprocessresearchanddevelopment": 25118000,
    "paymentstoacquirepropertyplantandequipment": 132000,
    "netcashprovidedbyusedininvestingactivities": -25250000,
    "proceedsfromissuanceinitialpublicoffering": 191500000,
    "proceedsfromissuanceofconvertiblepreferredstock": 88324000,
    "proceedsfromissuanceoflongtermdebt": 24850000,
    "netcashprovidedbyusedinfinancingactivities": 304646000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 242886000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 243765000,
    "interestpaidnet": 1007000,
    "conversionofstockamountconverted1": 27000,
    "noncashissuanceofwarrants": 47894000,
    "stockissued1": 5885000,
    "issuanceofcommonstockwarrantsinconnectionwithlongtermdebt": 419000,
    "capitalexpendituresincurredbutnotyetpaid": 339000,
    "noncashfinalinterestpaymentfee": 2063000,
    "operatingleaseliabilitiesarisingfromobtainingrightofuseassets": 796000,
    "conversionofwarrantliabilitiesintoequity": 144172000,
    "debtconversionconvertedinstrumentamount1": 142437000,
    "noncashinterestexpenserelatedparty": 590000,
    "increasedecreaseinprepaidexpensesandotherassetsrelatedpartiescurrent": 19000,
    "increasedecreaseinaccountspayableandaccruedexpensesrelatedparties": 460000,
    "warrantsandrightsoutstanding": 400000,
    "propertyplantandequipmentusefullife": "P3Y",
    "numberofoperatingsegments": 1,
    "incrementalcommonsharesattributabletoexerciseofwarrants": 7588000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 3593034,
    "operatingleaseliability": 796000,
    "financialliabilitiesfairvaluedisclosure": 413000,
    "warrantsandrightsoutstandingmeasurementinput": 7.5,
    "warrantsandrightsoutstandingmeasurementinputextensiblelist": "us-gaap:MeasurementInputExercisePriceMember",
    "warrantsandrightsoutstandingterm": "P1Y9M7D",
    "debtinstrumentterm": "P1Y9M7D",
    "debtinstrumentmeasurementinputextensiblelist": "us-gaap:MeasurementInputExpectedTermMember",
    "debtinstrumentmeasurementinput": 25,
    "debtinstrumentconversiondate": "2019-10-29",
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalue": 413000,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityissuanceofconvertiblepromissorynotes": 90750000,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityexchangeofconvertiblepromissorynotes": 2399000,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityissuanceofwarrants": 48313000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilityperiodincreasedecrease": 49546000,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisreclassofwarrantintoequity": 144172000,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisconversionofconvertiblepromissorynotesintocommonsharesuponinitialpublicoffering": 139847000,
    "propertyplantandequipmentgross": 471000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 8000,
    "depreciation": 8000,
    "accruedresearchanddevelopmentexpenses": 384000,
    "accruedemployeebenefitscurrent": 1052000,
    "accruedprofessionalfeescurrent": 478000,
    "otheraccruedliabilitiescurrent": 405000,
    "accountspayableandaccruedexpensesrelatedpartiescurrent": 100000,
    "relatedpartytransactionsharedoperatingexpensesduetotransactionswithrelatedparty": 400000,
    "relatedpartytransactionexpensesfromtransactionswithrelatedparty": 100000,
    "relatedpartytransactionsharedoperatingexpensesduefromtransactionswithrelatedparty": 100000,
    "debtinstrumentinterestrateeffectivepercentage": 0.065,
    "debtinstrumentincreasedecreaseforperiodnet": 49500000,
    "interestexpensedebt": 1600000,
    "lesseeoperatingleasetermofcontract": "P62M",
    "netrentablearea": 9420,
    "lesseeoperatingleaseoptiontoextend": "The lease contains an option to extend the term for one additional five-year period",
    "lesseeoperatingleaseexistenceofoptiontoterminate": "true",
    "lesseeoperatingleaserenewalterm": "P5Y",
    "operatingleaseexpense": 51000,
    "lesseeoperatingleaseliabilitypaymentsdue": 1700000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 166000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 171000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 176000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 181000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 186000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 80000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 164000,
    "operatingleaseweightedaverageremainingleaseterm1": "P5Y3M29D",
    "operatingleaseweightedaveragediscountratepercent": 0.0725,
    "operatingleasecost": 51000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 796000,
    "debtinstrumentcarryingamount": 25000000,
    "debtinstrumentunamortizeddiscount": 2223000,
    "debtinstrumentcovenantdescription": "Term Loan B is available through March 31, 2020, provided that (i) the Company has received at least $150.0 million of net cash proceeds in connection with the issuance and sale, subsequent to April 1, 2019, of its equity securities and subordinated debt, (ii) the Company has initiated Phase 3 clinical trials for vonoprazan, and (iii) no event of default has occurred.",
    "debtinstrumentpaymentterms": "The monthly payments consist of interest-only through May 31, 2021 or, in the event of positive data with respect to the Company’s Phase 3 clinical trial in both indications for vonoprazan sufficient to file an NDA with the FDA, through May 31, 2022.",
    "debtinstrumentfinalpaymentfee": 2100000,
    "accruedinterest": 200000,
    "longtermdebtmaturitiesrepaymentsofprincipalandinterestinnexttwelvemonths": 1843000,
    "longtermdebtmaturitiesrepaymentsofprincipalandinterestinyeartwo": 6609000,
    "longtermdebtmaturitiesrepaymentsofprincipalandinterestinyearthree": 9533000,
    "longtermdebtmaturitiesrepaymentsofprincipalandinterestinyearfour": 8920000,
    "longtermdebtmaturitiesrepaymentsofprincipalandinterestinyearfive": 5599000,
    "longtermdebtandinterest": 32504000,
    "debtinstrumentinterestandfinalpaymentfee": 7504000,
    "stockrepurchaseprogramremainingnumberofsharesauthorizedtoberepurchased": 2177861,
    "stockrepurchasedduringperiodshares": 17560,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 2700000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1400528,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 16260,
    "commonstockcapitalsharesreservedforfutureissuance": 11974974,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 5.12,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 6800000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P3Y9M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 4236248,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestingrestrictionsplacedonpreviouslyissuedshares": 3373408,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionssaleofunvestedcommonstock": 2524852,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsissuanceofunvestedrestrictedstockawards": 16260,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionssharevesting": 1660712,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 1400528,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 9.1,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 9.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P9Y8M8D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P0Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 30874000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y25D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.6017,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0158,
    "allocatedsharebasedcompensationexpense": 406000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -53578000,
    "incometaxreconciliationpermanentitems": 552000,
    "incometaxreconciliationchangeinfairvalueofwarrantsandconvertibledebt": 30622000,
    "incometaxreconciliationtaxcreditsresearch": 697000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 23046000,
    "incometaxreconciliationotheradjustments": 55000,
    "deferredtaxassetsoperatinglosscarryforwards": 6322000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsreserves": 204000,
    "deferredtaxassetsgoodwillandintangibleassets": 16050000,
    "deferredtaxassetsother": 921000,
    "deferredtaxassetsgross": 23497000,
    "deferredtaxassetsvaluationallowance": 23301000,
    "deferredtaxassetsnet": 196000,
    "deferredtaxliabilitiesother": 196000,
    "deferredtaxassetsoperatinglosscarryforwardsnotsubjecttoexpiration": 30100000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 900000,
    "researchanddevelopmenttaxcreditcarryforwardexpirationyear": 2038,
    "unrecognizedtaxbenefits": 176000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 176000
  }
]